Bernstein has reiterated its Outperform rating on PB Fintech, setting a target price of ₹1,720, suggesting a potential upside from the current market price of ₹1,660. Key points from the report include:
- Focus on New Ventures: All eyes are on PolicyBazaar’s hospital and HMO commentary, with the stock expected to respond to updates on these new ventures rather than just quarterly results.
- Favorable Market Structure: The growth outlook and market structure for the health insurance and unit-linked savings segments remain positive, benefiting PolicyBazaar.
- Strong Sales in Key Segments: Most insurers are reporting healthy sales in health insurance and unit-linked savings plans, which is expected to drive strong volume growth for PolicyBazaar.
- Q2 Sentiment: While Q2 results are anticipated to be good, Bernstein notes that sentiment heading into earnings is cautious, focusing more on future commentary rather than current quarterly numbers.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should perform their due diligence before making investment decisions
